Mirae Asset Global Investments Co., Ltd. Allogene Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$30.9 Billion
Q3 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,578 shares of ALLO stock, worth $10,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,578

Previous 8,450 1.51%

Holding current value

$10,550

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$1.03 - $1.66 $131 - $212	128 Added 1.51%	8,578 $10,000
Q2 2025 Jul 21, 2025	BUY	$0.95 - $1.7 $1,362 - $2,437	1,434 Added 20.44%	8,450 $9,000
Q1 2025 Apr 24, 2025	BUY	$1.4 - $2.84 $40 - $82	29 Added 0.42%	7,016 $10,000
Q4 2024 Jan 27, 2025	SELL	$1.84 - $3.22 $1,059 - $1,854	-576 Reduced 7.62%	6,987 $14,000
Q3 2024 Oct 23, 2024	BUY	$2.08 - $3.5 $2,766 - $4,655	1,330 Added 21.34%	7,563 $21,000

Q2 2024 Jul 30, 2024	SELL	$2.23 - $4.38 $793,166 - $1.56 Million	-355,680 Reduced 98.28%	6,233 $14,000
Q1 2024 May 01, 2024	BUY	$2.92 - $5.63 $485,984 - $937,017	166,433 Added 85.14%	361,913 $1.62 Million
Q4 2023 Jan 24, 2024	SELL	$2.28 - $3.5 $531,269 - $815,545	-233,013 Reduced 54.38%	195,480 $627,000
Q3 2023 Oct 26, 2023	BUY	$3.17 - $5.96 $103,880 - $195,309	32,770 Added 8.28%	428,493 $1.36 Million
Q2 2023 Aug 10, 2023	BUY	$4.53 - $6.74 $139,292 - $207,248	30,749 Added 8.42%	395,723 $1.97 Million
Q1 2023 May 04, 2023	BUY	$4.92 - $8.21 $139,260 - $232,384	28,305 Added 8.41%	364,974 $1.8 Million
Q4 2022 Feb 09, 2023	SELL	$5.62 - $11.11 $273,087 - $539,857	-48,592 Reduced 12.61%	336,669 $2.12 Million
Q3 2022 Nov 10, 2022	BUY	$10.32 - $17.28 $609,550 - $1.02 Million	59,065 Added 18.11%	385,261 $4.16 Million
Q2 2022 Jul 26, 2022	BUY	$6.78 - $12.28 $763,190 - $1.38 Million	112,565 Added 52.69%	326,196 $3.72 Million
Q1 2022 May 10, 2022	SELL	$7.65 - $15.29 $297,041 - $593,695	-38,829 Reduced 15.38%	213,631 $1.95 Million
Q4 2021 Feb 08, 2022	BUY	$13.13 - $24.52 $477,643 - $891,988	36,378 Added 16.84%	252,460 $3.77 Million
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $895,614 - $1.18 Million	42,628 Added 24.58%	216,082 $5.55 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $408,749 - $622,955	17,401 Added 11.15%	173,454 $4.52 Million
Q1 2021 May 13, 2021	BUY	$25.79 - $39.02 $1.81 Million - $2.74 Million	70,127 Added 81.61%	156,053 $5.51 Million
Q4 2020 Feb 10, 2021	BUY	$25.24 - $43.45 $871,209 - $1.5 Million	34,517 Added 67.14%	85,926 $2.17 Million
Q3 2020 Nov 12, 2020	BUY	$32.38 - $44.96 $521,997 - $724,800	16,121 Added 45.68%	51,409 $1.94 Million
Q2 2020 Aug 11, 2020	BUY	$18.39 - $54.04 $648,946 - $1.91 Million	35,288 New	35,288 $1.51 Million

Others Institutions Holding ALLO

# of Institutions

182

Shares Held

138M

Call Options Held

76.6K

Put Options Held

36.2K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $177M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Allogene Therapeutics, Inc. Transaction History